Naren K.
About Naren K.
Naren K. serves as the Executive Director of Supply Chain (Network Planning and Business Systems) at Kite Pharma, where he enhances sales and operations planning processes. With a robust background in manufacturing and operations across various companies, he has held significant roles at Amgen and Boston Scientific, among others.
Current Role at Kite Pharma
Naren K. serves as the Executive Director of Supply Chain, focusing on Network Planning and Business Systems at Kite Pharma since 2020. In this role, he enhances the Sales and Operations Planning (S&OP) and Long Range Planning (LRP) processes across Technical Operations, Commercial, and Finance sectors. His work supports effective executive decision-making and drives improvements in operational efficiency.
Previous Experience at Kite Pharma
Prior to his current position, Naren K. worked at Kite Pharma as Executive Director of Manufacturing from 2018 to 2020. During this time in Santa Monica, California, he was responsible for overseeing manufacturing operations and ensuring alignment with corporate strategies.
Career at Amgen
Naren K. has extensive experience at Amgen, where he held multiple roles from 2008 to 2018. He served as Director of Operations Strategic Planning, Senior Manager, and Executive Director of Manufacturing. His responsibilities included advancing digital supply chain capabilities and integrating enterprise business systems to enhance operational effectiveness.
Educational Background
Naren K. holds a Bachelor of Technology (B.Tech.) in Mechanical Engineering from the Indian Institute of Technology, Madras. He also earned a Master's degree in Manufacturing Engineering from Boston University and an MBA in Operations Management and Finance from UCLA Anderson School of Management.
Early Career Experience
Naren K. began his career in engineering roles, working at Polaroid as an Engineer/Scientist from 1992 to 1997 and at Boston Scientific Inc as a Senior Development Engineer from 1997 to 2000. He also held positions at Cereon Genomics and Transform Pharmaceuticals, where he managed operations and contract manufacturing.